Cargando…

Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity

Resistance to anti-cancer monoclonal antibody (mAb) therapy remains a clinical challenge. Previous work in our laboratory has shown that T cell help in the form of interleukin-2 maintains long-term NK cell viability and NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC). Lack of such T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhaoming, Yin, Chaobo, Lum, Lawrence G., Simons, Andrean, Weiner, George J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656063/ https://www.ncbi.nlm.nih.gov/pubmed/34886888 http://dx.doi.org/10.1186/s13045-021-01216-w

Ejemplares similares

T cells, particularly activated CD4(+) cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity
por: Wang, Zhaoming, et al.
Publicado: (2021)

Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
por: Murin, Charles D.
Publicado: (2020)

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy
por: Wang, Wei, et al.
Publicado: (2015)

Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity
por: Bernard, Nicole F., et al.
Publicado: (2017)

Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
por: Thakur, Archana, et al.
Publicado: (2021)

In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer
por: Thakur, Archana, et al.
Publicado: (2015)

Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia
por: Kubicka, Ewa, et al.
Publicado: (2022)

The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity.
por: Kroesen, B. J., et al.
Publicado: (1996)

Compromised NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Chronic SIV/SHIV Infection
por: He, Xuan, et al.
Publicado: (2013)

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
por: Yano, Hiroshi, et al.
Publicado: (2014)

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
por: Zitron, Ian M, et al.
Publicado: (2013)

NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity
por: Arora, Gunjan, et al.
Publicado: (2018)

Reovirus activated NK cells show enhanced cetuximab mediated antibody-dependent cellular cytotoxicity against colorectal cancer cells
por: Zhao, Xing, et al.
Publicado: (2015)

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells
por: Lutz, Sebastian, et al.
Publicado: (2023)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Khanna, Vidhi, et al.
Publicado: (2021)

Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients
por: Reiners, Katrin S., et al.
Publicado: (2013)

Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer
por: Huan, Tian, et al.
Publicado: (2023)

LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicity
por: Leijonhufvud, Caroline, et al.
Publicado: (2021)

Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness
por: Thakur, Archana, et al.
Publicado: (2021)

Antibody-dependent cellular cytotoxicity by allosensitized human T cells
Publicado: (1978)

Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity
por: Alderson, Kory L., et al.
Publicado: (2011)

Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity
por: Binder, Christian, et al.
Publicado: (2021)

LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer
por: Qiao, Guilin, et al.
Publicado: (2022)

Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
por: Isitman, Gamze, et al.
Publicado: (2012)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

P10-07. Extremely rapid degranulation of NK cells activated by HIV-specific antibody dependent cellular cytotoxicity
por: Chung, A, et al.
Publicado: (2009)

Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity
por: Marchitto, Lorie, et al.
Publicado: (2023)

Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy
por: Zahavi, David, et al.
Publicado: (2018)

Influenza and Antibody-Dependent Cellular Cytotoxicity
por: Von Holle, Tarra A., et al.
Publicado: (2019)

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)
por: Jensen, Sanne Skov, et al.
Publicado: (2015)

Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells
por: Kim, Yoseop, et al.
Publicado: (2019)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
por: Freedman, Joshua D, et al.
Publicado: (2017)

SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity
por: Antosova, Zuzana, et al.
Publicado: (2022)

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
por: Urbanska, Katarzyna, et al.
Publicado: (2014)

Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
por: Sanchez-Martinez, Diego, et al.
Publicado: (2018)

Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
por: Park, Ji-Eun, et al.
Publicado: (2020)

Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity
por: Kwok, Hang Fai, et al.
Publicado: (2011)

Antibody–receptor interactions mediate antibody-dependent cellular cytotoxicity
por: Sun, Yue, et al.
Publicado: (2021)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

NK Cells Activated through Antibody-Dependent Cell Cytotoxicity and Armed with Degranulation/IFN-γ Production Suppress Antibody-dependent Enhancement of Dengue Viral Infection
por: Sun, Peifang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ljmttlab91bf8fr0g0o5qkv4kl